dc.creatorOliveira, Josenilson Campos de
dc.creatorSiviero-Miachon, Adriana A
dc.creatorSpinola-Castro, Angela Maria
dc.creatorBelangero, Vera Maria Santoro
dc.creatorGuerra-Junior, Gil
dc.date2008-Jul
dc.date2015-11-27T13:13:12Z
dc.date2015-11-27T13:13:12Z
dc.date.accessioned2018-03-29T01:07:31Z
dc.date.available2018-03-29T01:07:31Z
dc.identifierArquivos Brasileiros De Endocrinologia E Metabologia. v. 52, n. 5, p. 783-91, 2008-Jul.
dc.identifier1677-9487
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/18797585
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/197980
dc.identifier18797585
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1298213
dc.descriptionGrowth failure is frequent and a clinically important issue in children with chronic kidney disease (CKD). Many factors contribute to impaired growth in these children, including abnormalities in the growth hormone (GH)--insulin-like growth factor 1 (IGF-1) axis, malnutrition, acidosis, renal bone disease and glucocorticoid associated treatment. The management of growth failure in children with CKD is complicated by the presence of other-disease related complications requiring medical intervention. Despite evidence of GH efficacy and safety in this population, this therapy is still underutilized. This review shows the impact, the causes and the treatment of growth failure in children with CKD.
dc.description52
dc.description783-91
dc.languagepor
dc.relationArquivos Brasileiros De Endocrinologia E Metabologia
dc.relationArq Bras Endocrinol Metabol
dc.rightsaberto
dc.rights
dc.sourcePubMed
dc.subjectAdrenal Cortex Hormones
dc.subjectBody Height
dc.subjectGrowth Disorders
dc.subjectHuman Growth Hormone
dc.subjectHumans
dc.subjectInsulin-like Growth Factor I
dc.subjectKidney Failure, Chronic
dc.title[short Stature In Chronic Kidney Disease: Physiopathology And Treatment With Growth Hormone].
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución